Molar Extinction Coefficient of Single-Wall Carbon Nanotubes
Schöppler, Friedrich, Mann, Christoph, Hain, Tilman C, Neubauer, Felix M, Privitera, Giulia, Bonaccorso, Francesco, Chu, Daping, Ferrari, Andrea C, Hertel, Tobias
Published in Journal of physical chemistry. C (04.08.2011)
Published in Journal of physical chemistry. C (04.08.2011)
Get full text
Journal Article
Vascular Endothelial Growth Factor-D and Its Receptor VEGFR-3: Two Novel Independent Prognostic Markers in Gastric Adenocarcinoma
JÜTTNER, Stefan, WISSMANN, Christoph, JÖNS, Thomas, VIETH, Michael, HERTEL, Johannes, GRETSCHEL, Stephan, SCHLAG, Peter M, KEMMNER, Wolfgang, HBCKER, Michael
Published in Journal of clinical oncology (10.01.2006)
Published in Journal of clinical oncology (10.01.2006)
Get full text
Journal Article
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma
Leypoldt, Lisa B, Tichy, Diana, Besemer, Britta, Hänel, Mathias, Raab, Marc S, Mann, Christoph, Munder, Markus, Reinhardt, Hans Christian, Nogai, Axel, Görner, Martin, Ko, Yon-Dschun, de Wit, Maike, Salwender, Hans, Scheid, Christof, Graeven, Ullrich, Peceny, Rudolf, Staib, Peter, Dieing, Annette, Einsele, Hermann, Jauch, Anna, Hundemer, Michael, Zago, Manola, Požek, Ema, Benner, Axel, Bokemeyer, Carsten, Goldschmidt, Hartmut, Weisel, Katja C
Published in Journal of clinical oncology (01.01.2024)
Published in Journal of clinical oncology (01.01.2024)
Get full text
Journal Article
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial
Leypoldt, Lisa B., Besemer, Britta, Asemissen, Anne Marie, Hänel, Mathias, Blau, Igor Wolfgang, Görner, Martin, Ko, Yon-Dschun, Reinhardt, Hans Christian, Staib, Peter, Mann, Christoph, Lutz, Raphael, Munder, Markus, Graeven, Ullrich, Peceny, Rudolf, Salwender, Hans, Jauch, Anna, Zago, Manola, Benner, Axel, Tichy, Diana, Bokemeyer, Carsten, Goldschmidt, Hartmut, Weisel, Katja C.
Published in Leukemia (01.03.2022)
Published in Leukemia (01.03.2022)
Get full text
Journal Article
Real-World Analysis of Teclistamab in 115 RRMM Patients from Germany
Riedhammer, Christine, Bassermann, Florian, Besemer, Britta, Bewarder, Moritz, Brunner, Franziska, Carpinteiro, Alexander, Einsele, Hermann, Faltin, Josefine, Frenking, Jan, Gezer, Deniz, Goldman-Mazur, Sarah, Hanel, Mathias, Hoegner, Marion, Kortüm, K. Martin, Krönke, Jan, Kull, Miriam, Leitner, Theo, Mann, Christoph, Mecklenbrauck, Rabea, Merz, Maximilian, Morgner, Anke, Nogai, Axel, Raab, Marc S., Teipel, Raphael, Wäsch, Ralph, Rasche, Leo
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells
Mack, Elisabeth K. M., Hartmann, Sören, Ross, Petra, Wollmer, Ellen, Mann, Christoph, Neubauer, Andreas, Brendel, Cornelia, Hoffmann, Jörg
Published in Annals of hematology (01.04.2022)
Published in Annals of hematology (01.04.2022)
Get full text
Journal Article
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone (Isa-KRd) in Patients with High-Risk Newly Diagnosed Multiple Myeloma: Planned Interim Analysis of the GMMG-Concept Trial
Weisel, Katja, Besemer, Britta, Haenel, Mathias, Lutz, Raphael, Mann, Christoph, Munder, Markus, Goerner, Martin, Reinhardt, Hans Christian, Nogai, Axel, Ko, Yon-Dschun, De Wit, Maike, Salwender, Hans, Scheid, Christoph, Graeven, Ullrich, Peceny, Rudolf, Staib, Peter, Dieing, Annette, Jauch, Anna, Zago, Manola, Benner, Axel, Tichy, Diana, Bokemeyer, Carsten, Goldschmidt, Hartmut, Leypoldt, Lisa B.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
CD8+ CD28− regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study
Kriegsmann, Katharina, Ton, Gigi Nu Hoang Quy, Awwad, Mohamed H. S., Benner, Axel, Bertsch, Uta, Besemer, Britta, Hänel, Mathias, Fenk, Roland, Munder, Markus, Dürig, Jan, Blau, Igor W., Huhn, Stefanie, Hose, Dirk, Jauch, Anna, Mann, Christoph, Weinhold, Niels, Scheid, Christof, Schroers, Roland, von Metzler, Ivana, Schieferdecker, Aneta, Thomalla, Jörg, Reimer, Peter, Mahlberg, Rolf, Graeven, Ullrich, Kremers, Stephan, Martens, Uwe M., Kunz, Christian, Hensel, Manfred, Seidel-Glätzer, Andrea, Weisel, Katja C., Salwender, Hans J., Müller-Tidow, Carsten, Raab, Marc S., Goldschmidt, Hartmut, Mai, Elias K., Hundemer, Michael
Published in Leukemia (01.07.2024)
Published in Leukemia (01.07.2024)
Get full text
Journal Article
OA-18 Association of Cardiac Biomarkers and Adverse Events with a Carfilzomib-Containing Quadruplet in High-Risk Newly Diagnosed Multiple Myeloma Patients: Correlative Program of the GMMG-CONCEPT Trial
Leypoldt, Lisa, Guo, Linlin, Besemer, Britta, Hänel, Mathias, Raab, Marc-Steffen, Mann, Christoph, Michel, Christian S., Reinhardt, Hans Christian, Blau, Igor Wolfgang, Görner, Martin, Ko, Yon-Dschun, de Wit, Maike, Salwender, Hans, Scheid, Christof, Graeven, Ullrich, Peceny, Rudolf, Staib, Peter, Dieing, Annette, Goldschmidt, Hartmut, Bokemeyer, Carsten, Zeller, Tanja, Westermann, Dirk, Weisel, Katja, Twerenbold, Raphael, Beitzen-Heineke, Antonia
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
OA-53 Isa-KRd in High-Risk Newly Diagnosed Multiple Myeloma – 4-Year-Follow-Up from the GMMG-CONCEPT trial
Leypoldt, Lisa, Besemer, Britta, Hänel, Mathias, Raab, Marc-Steffen, Mann, Christoph, Michel, Christian S., Reinhardt, Hans Christian, Blau, Igor Wolfgang, Görner, Martin, Ko, Yon-Dschun, de Wit, Maike, Salwender, Hans, Scheid, Christof, Graeven, Ullrich, Peceny, Rudolf, Staib, Peter, Dieing, Annette, Einsele, Hermann, Jauch, Anna, Hundemer, Michael, Požek, Ema, Benner, Axel, Bokemeyer, Carsten, Goldschmidt, Hartmut, Weisel, Katja
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma
Leypoldt, Lisa B, Tichy, Diana, Besemer, Britta, Hanel, Mathias, Raab, Marc S, Mann, Christoph, Munder, Markus, Reinhardt, Hans Christian, Nogai, Axel, Gorner, Martin, Ko, Yon-Dschun, Wit, Maike de, Salwender, Hans, Scheid, Christof, Graeven, Ullrich, Peceny, Rudolf, Staib, Peter, Dieing, Annette, Einsele, Hermann, Jauch, Anna, Hundemer, Michael, Zago, Manola, Pozek, Ema, Benner, Axel, Bokemeyer, Carsten, Goldschmidt, Hartmut, Weisel, Katja C
Published in Future oncology (London, England) (30.09.2024)
Published in Future oncology (London, England) (30.09.2024)
Get more information
Journal Article
Addition of Isatuximab to Lenalidomide, Bortezomib and Dexamethasone As Induction Therapy for Newly-Diagnosed, Transplant-Eligible Multiple Myeloma Patients: The Phase III GMMG-HD7 Trial
Goldschmidt, Hartmut, Mai, Elias K, Nievergall, Eva, Fenk, Roland, Bertsch, Uta, Tichy, Diana, Besemer, Britta, Dürig, Jan, Schroers, Roland, Metzler, Ivana v., Haenel, Mathias, Mann, Christoph, Asemissen, Anne-Marie, Heilmeier, Bernhard, Huhn, Stefanie, Kriegsmann, Katharina, Weinhold, Niels, Luntz, Steffen P., Holderried, Tobias A.W., Trautmann-Grill, Karolin, Gezer, Deniz, Klaiber-Hakimi, Maika, Mueller, Martin, Khandanpour, Cyrus, Knauf, Wolfgang, Munder, Markus, Geer, Thomas, Riesenberg, Hendrik, Thomalla, Joerg, Hoffmann, Martin, Raab, Marc-Steffen, Salwender, Hans, Weisel, Katja
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Depth of response to isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: Interim analysis of the GMMG-CONCEPT trial
Weisel, Katja, Asemissen, Anne Marie, Besemer, Britta, Haenel, Mathias, Blau, Igor W., Goerner, Martin, Ko, Yon-Dschun, Dürig, Jan, Staib, Peter, Mann, Christoph, Lutz, Raphael, Munder, Markus, Graeven, Ullrich, Peceny, Rudolph, Salwender, Hans, Zago, Manola, Benner, Axel, Tichy, Diana, Bokemeyer, Carsten, Goldschmidt, Hartmut
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
OA-43 Analysis of sustained MRD-negativity and progression-free survival of Isa-KRd in high-risk newly diagnosed multiple myeloma – additional data from planned interim analysis of the GMMG-CONCEPT trial
Leypoldt, Lisa, Tichy, Diana, Besemer, Britta, Hänel, Mathias, Raab, Marc, Mann, Christoph, Munder, Markus, Reinhardt, Hans Christian, Nogai, Axel, Görner, Martin, Ko, Yon-Dschun, de Wit, Maike, Salwender, Hans, Scheid, Christof, Graeven, Ullrich, Peceny, Rudolf, Staib, Peter, Dieing, Annette, Einsele, Hermann, Jauch, Anna, Zago, Manola, Benner, Axel, Bokemeyer, Carsten, Goldschmidt, Hartmut, Weisel, Katja
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
Prospective monitoring of immune signatures in newly diagnosed high risk multiple myeloma patients under treatment with Isatuximab, Carfilzomib, Lenalidomide and Dexamethasone (I-KRd): First results of the GMMG-CONCEPT trial
Asemissen, Anne Marie, Autenrieth, Stella, Bieber, Kristin, Gouttefangeas, Cecile, Rammensee, Hans-Georg, Besemer, Britta, Mann, Christoph, Blau, Igor Wolfgang, Schieferdecker, Aneta, Bokemeyer, Carsten, Goldschmidt, Hartmut, Weisel, Katja
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Get full text
Journal Article
Isatuximab, Carfilzomib, Lenalidomide and Dexamethasone (I-KRd) in front-line treatment of high-risk Multiple Myeloma: Results of the Safety Run-In cohort in the phase II, multicenter GMMG-CONCEPT trial
Weisel, Katja, Asemissen, Anne Marie, Schieferdecker, Aneta, Besemer, Britta, Zago, Manola, Mann, Christoph, Lutz, Raphael, Benner, Axel, Tichy, Diana, Bokemeyer, Carsten, Goldschmidt, Hartmut
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Get full text
Journal Article
Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation
Christen, Deborah, Sohlbach, Kristina, Metzelder, Stephan K., Wollmer, Ellen, Hoeffkes, Heinz-Gert, Naumann, Ralph, Burchardt, Alexander, Rummel, Mathias, Trenker, Corinna, Dohse, Marius, Mack, Elisabeth, Klameth, Andreas, Mann, Christoph, Kostrewa, Philippe, Brendel, Cornelia, Wündisch, Thomas, Neubauer, Andreas, Wilhelm, Christian, Burchert, Andreas
Published in Leukemia & lymphoma (03.07.2019)
Published in Leukemia & lymphoma (03.07.2019)
Get full text
Journal Article